1. Home
  2. ICUCW vs TOYO Comparison

ICUCW vs TOYO Comparison

Compare ICUCW & TOYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICUCW
  • TOYO
  • Stock Information
  • Founded
  • ICUCW N/A
  • TOYO 2022
  • Country
  • ICUCW United States
  • TOYO Japan
  • Employees
  • ICUCW 19
  • TOYO N/A
  • Industry
  • ICUCW Biotechnology: Pharmaceutical Preparations
  • TOYO
  • Sector
  • ICUCW Health Care
  • TOYO
  • Exchange
  • ICUCW Nasdaq
  • TOYO NYSE
  • Market Cap
  • ICUCW N/A
  • TOYO 153.8M
  • IPO Year
  • ICUCW 2021
  • TOYO N/A
  • Fundamental
  • Price
  • ICUCW $0.02
  • TOYO $3.60
  • Analyst Decision
  • ICUCW
  • TOYO
  • Analyst Count
  • ICUCW 0
  • TOYO 0
  • Target Price
  • ICUCW N/A
  • TOYO N/A
  • AVG Volume (30 Days)
  • ICUCW N/A
  • TOYO 13.5K
  • Earning Date
  • ICUCW N/A
  • TOYO 08-21-2025
  • Dividend Yield
  • ICUCW N/A
  • TOYO N/A
  • EPS Growth
  • ICUCW N/A
  • TOYO 350.49
  • EPS
  • ICUCW N/A
  • TOYO 1.09
  • Revenue
  • ICUCW N/A
  • TOYO $176,957,128.00
  • Revenue This Year
  • ICUCW N/A
  • TOYO N/A
  • Revenue Next Year
  • ICUCW N/A
  • TOYO N/A
  • P/E Ratio
  • ICUCW N/A
  • TOYO $3.31
  • Revenue Growth
  • ICUCW N/A
  • TOYO 183.69
  • 52 Week Low
  • ICUCW N/A
  • TOYO $1.36
  • 52 Week High
  • ICUCW N/A
  • TOYO $7.22
  • Technical
  • Relative Strength Index (RSI)
  • ICUCW N/A
  • TOYO N/A
  • Support Level
  • ICUCW N/A
  • TOYO N/A
  • Resistance Level
  • ICUCW N/A
  • TOYO N/A
  • Average True Range (ATR)
  • ICUCW 0.00
  • TOYO 0.00
  • MACD
  • ICUCW 0.00
  • TOYO 0.00
  • Stochastic Oscillator
  • ICUCW 0.00
  • TOYO 0.00

About ICUCW SeaStar Medical Holding Corporation Warrant

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.

About TOYO TOYO CO LTD

Toyo Co Ltd along with its subsidiaries, is engaged in research and development, production, and sales of solar cells. Geographically, the company generates revenue from Asia and the USA, out of which the majority of revenue is generated from Asia.

Share on Social Networks: